Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape - Microbiome Therapeutics,Human Microbiome,Microbiome Therapy
07-Mar-2023
Global
Technology Research
DA9A-01-00-00-00
HC03643-GL-TR_27488
This study identifies and analyzes research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases. Over the last decade, gut microbiome therapeutics have largely relied on untargeted approaches, such as fecal microbiome therapy (FMT), probiotics, prebiotics, and synbiotics. However, technological advancements have resulted in the development of and demand for targeted interventions for microbiome therapeutics. Emerging technologies in this space include targeted drugs, cultured commensals, bio-engineered commensals, and bacteriophage therapies. There has been an increase in investments and government funding for the development of gut microbiome therapeutics. The market for gut microbiome therapeutics is expected to see significant growth over the next five years.
Key Questions this Study will Answer:
1. What are the factors driving and restraining the development of gut microbiome therapeutics?
2. What are the venture funding and patent landscapes like for gut microbiome therapeutics?
3. Who are the key industry participants developing gut microbiome therapeutics?
4. What are the clinical trends emerging across each targeted and untargeted approach for the development of gut microbiome therapeutics?
5. What are the key growth opportunities emerging from the shifts in this space? How should market players and stakeholders leverage these opportunities?
Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Gut Microbiome Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Introduction
Growth Drivers
Growth Driver Analysis
Growth Restraints
Growth Restraints Analysis
Scope of Analysis
Segmentation
Research Methodology
Regulatory Landscape for Microbiome in Europe
Regulatory Landscape for Microbiome in Europe (continued)
Regulatory Landscape for Microbiome across the Asia-Pacific
Regulatory Landscape for Microbiome across the Asia-Pacific (continued)
Regulatory Landscape for Microbiome in North America
Summary of Global Probiotic Regulations
Untargeted Approaches for Treating Oncology Conditions
Untargeted Approaches for Treating Gastrointestinal Conditions
Untargeted Approaches for Treating Metabolic Conditions
Untargeted Approaches for Treating Neurological Conditions
Untargeted Approaches for Treating Other Conditions
Analyst Insight—Untargeted Approaches
Targeted Approaches for Treating Oncology Conditions
Targeted Approaches for Treating Gastrointestinal Conditions
Targeted Approaches for Treating Neurological Conditions
Targeted Approaches for Treating Other Conditions
Analyst Insights—Targeted Approach
Analyst Insights—Targeted Approach (continued)
Innovation Spotlight in Untargeted Approach
Innovation Spotlight in Targeted Approach
Innovation Spotlight in Targeted Approach (continued)
R&D Activities (Basic/Applied and Exploratory Research)
Research Landscape: Analyst Insights
Research Landscape: Analyst Insights (continued)
Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics
Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics (continued)
Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics (continued)
Patent Landscape for Microbiome Industry
Patent Landscape for Microbiome Industry (continued)
Significant Venture Capital and Private Equity Funding Boost Innovations in the Gut Microbiome Industry
Government Grant Funding Supporting Innovations in the Gut Microbiome Industry
Growth Opportunity 1: Gut Microbiome Targeted Approaches
Growth Opportunity 1: Gut Microbiome Targeted Approaches (continued)
Growth Opportunity 2: Gut-Brain Axis Applications
Growth Opportunity 2: Gut-Brain Axis Applications (continued)
Growth Opportunity 3: Oncological Applications
Growth Opportunity 3: Oncological Applications (continued)
Your Next Steps
Why Frost, Why Now?
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| New Title | Global Gut Microbiome Growth Opportunities Market - Growth Opportunities, Analysis, Forecast, Global, 2023 |
|---|---|
| New Subtitle | Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape - Microbiome Therapeutics,Human Microbiome,Microbiome Therapy |
| Deliverable Type | Technology Research |
| Author | Priyanka Jain |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Microbiome Therapeutics |
| Keyword 2 | Microbiome Therapy |
| Keyword 3 | Human Microbiome |
| Podcast | No |
| WIP Number | DA9A-01-00-00-00 |
Global Gut Microbiome Growth Opportunities
$4,950.00
Special Price $3,712.50 save 25 %